European pharma industry affirms efforts to avoid animal testing

7 March 2022
efpia-big

The European pharma industry has responded to a “non-legislative resolution” detailing plans and actions to move away from using animals in medical research.

The European Federation of Pharmaceutical Industries and Associations (EFPIA), a Brussels-based trade association and lobbying group,  said it supported a statement from the European Commission that it is “not possible to predict when scientifically valid methods will become available that can replace particular animal procedures.”

The group said its members were committed to the science-based introduction of methods to replace the use of animals, and that its members aimed to “lead progress on this by engaging in a wide range of practical activities.”

Industry initiative

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical